Godavari Drugs

Stock Price vs Company Growth
1d
0.5%
1w
1.2%
1m
1.4%
3m
30.8%
6m
33.1%
1y
36.8%
5y
14.4%
10y
12.3%
all
11.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 122 0.5%
93
135
Company Overview

Sales
106 Cr
Growth: -14.5%
Profit after Tax
3.73 Cr
Growth: 8.5%
Micro Cap
124 Cr
P/E: 22.6x
Industry P/E: 33.7x
Fundamentals

Sales (Cr) ₹ 106
Growth -14.5%
EBITDA 9.7%
P/S 1.2x
Dividend 0.0%
P/E 22.6x
Book Value ₹ 69.7
PEG Ratio -1.6x
ROE 7.2%
P/B 1.8x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company’s principal activity is to manufacture and sell bulk drugs. It undertakes contract manufacturing from various organizations. The products include Pyrazinamide and Ethambutol HCL.
Investors (11)